Business

Why Capricor May Be the Next Big Name in Duchenne Muscular Dystrophy

Capricor Therapeutics Inc. (NASDAQ: CAPR) shares more than doubled on Monday after the firm announced interim analysis for its Duchenne muscular dystrophy (DMD) midstage trial. Overall, there were significant results ...
Read Full Story »

Oil & Gas Midcap Callon Buys Rival Carrizo for $3.2 Billion

Two midcap energy companies announced Monday an agreement under which Callon Petroleum Co. (NYSE: CPE) will acquire Carrizo Oil & Gas Inc. (NASDAQ: CRZO) in an all-stock deal valued at ...
Read Full Story »

Alkermes Looks to Expand Its Schizophrenia Treatment to Bipolar Patients

Alkermes PLC (NASDAQ: ALKS) shares made a handy gain on Monday after the firm announced that it would be expanding its New Drug Application (NDA) for ALKS 3831 to encompass ...
Read Full Story »

Does Citigroup Deserve More Credit for This Bottom-Line Beat?

Citigroup Inc. (NYSE: C) released its second-quarter financial results before the markets opened on Monday. The bank said that it had $1.95 in earnings per share (EPS) and $18.76 billion ...
Read Full Story »

JPMorgan, Wells Fargo, Citigroup, Goldman Sachs and More Major Financial Earnings This Week

Practically all the major banks are reporting their second-quarter financial results this week. In general, financial stocks have made solid gains so far this year, despite a tumultuous May. At ...
Read Full Story »

How Much Will Unhappy Amazon Workers Disrupt Prime Day?

Amazon's Prime Day, during which members of its subscription services get deals on hundreds of thousands of products and appearances by famous artists, kicks off at 3 a.m. ET on ...
Read Full Story »

This Famous Newspaper Will Fire Its Entire Staff

Call it part of the implosion of the American newspaper industry. A 126-year-old, Pulitzer Prize-winning daily newspaper will lay off its entire staff as it changes ownership. It is one ...
Read Full Story »

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the most recent settlement date, June 28. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Why Canaccord Genuity Is on the Sideline About Illumina

Illumina Inc. (NASDAQ: ILMN) shares dropped on Friday after the firm announced a preliminary revenue miss and a 50% cut to its 2019 revenue growth guidance. As a result, ...
Read Full Story »

Trump Weighs In on Facebook Cryptocurrency: He Doesn’t Like It

When Facebook Inc. (NASDAQ: FB) last month announced a new cryptocurrency called Libra, reaction was mixed. Even though the digital currency would be managed by a consortium called the Libra ...
Read Full Story »

Health Catalyst Closes in on IPO

Health Catalyst has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). The company expects to price its 6.0 million ...
Read Full Story »

What’s So Great About Hookipa Pharma’s HPV Cancer Treatment

Hookipa Pharma Inc. (NASDAQ: HOOK) is not a household name, or even well-known within the biotech industry, but it is making waves on Friday after the firm announced an update ...
Read Full Story »

Ford, VW: Tying Two Rocks Together Does Not Make Them Float

When Ford Motor Co. (NYSE: F) and Volkswagen announced an alliance in January, investors were underwhelmed. Since that announcement, not much has happened. Until Friday morning. Ford and VW have ...
Read Full Story »

The World’s Best Vineyard Is…Not in France

According to a new ranking by the World’s Best Vineyards Academy, the top vineyard in the world is many miles from France or the Napa Valley: It’s Zuccardi Valle de ...
Read Full Story »

Will Bed Bath & Beyond Be the Next Major Retailer to Go Bankrupt?

The financial and operational situation at Bed Bath & Beyond Inc. (NASDAQ: BBBY) is deteriorating quickly. Like a handful of other large, battered retailers, if it cannot sharply reverse course, ...
Read Full Story »